There are 2789 resources available
1021P - Long non-coding RNAs influence cancer immunotherapy efficacy through regulating T-cell infiltration and activity or tumor antigenicity
Presenter: Anlin Li
Session: ePoster Display
1022P - Frequency of PD1-negative and PD-1-positive ILCs in breast cancer patients depending on PD-L1 status
Presenter: Vladimir Alifanov
Session: ePoster Display
1023P - A novel microbiome-derived peptide, SG-3-00802 reverses resistance to anti-programmed death protein-1 (PD-1) therapy
Presenter: Helena Kiefel
Session: ePoster Display
1025TiP - SOLTI-1904: Efficacy of spartalizumab across multiple cancer-types in patients with PD1-high mRNA expressing tumors defined by a single and pre-specified cutoff (ACROPOLI)
Presenter: Aleix Prat
Session: ePoster Display
968P - Association between use of antibiotics (ATB) and clinical outcomes with tislelizumab (tisle) monotherapy
Presenter: Zheng-Gang Ren
Session: ePoster Display
969P - Effect of angiotensin II inhibition on non-small cell lung cancer response to immune checkpoint blockers
Presenter: Patricia Pereira
Session: ePoster Display
970P - Assessment of anti-PD-1 antibody and immune complex binding to Fcγ receptors and clinical implications
Presenter: Elena Daveri
Session: ePoster Display
971P - Is there a clinical benefit of nivolumab + ipilimumab in patients older than 75 years with advanced solid tumors?
Presenter: Thierry Landre
Session: ePoster Display
973P - A phase II study of PDR001 among patients with recurrent and/or metastatic esophageal squamous cell carcinoma: An interim analysis of KM-12
Presenter: Dong Ki Lee
Session: ePoster Display